Ca2+/cAMP ratio: An inflammatory index for diabetes, hypertension, and COVID-19

doi:10.4239/wjd.v14.i3.343

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2769)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

107

WORD

HTML

1972

Figures (1-1)

307

Sum=2418

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

254

Sum=351

Mar 15, 2023 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Diabetes. Mar 15, 2023; 14(3): 343-346
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.343

Ca²⁺/cAMP ratio: An inflammatory index for diabetes, hypertension, and COVID-19

Leandro Bergantin

Leandro Bergantin, Department of Pharmacology, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil

Author contributions: Bergantin LB is the sole author.

Conflict-of-interest statement: There are no conflicts of interest to report.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Leandro Bergantin, PhD, Professor, Department of Pharmacology, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669 Vila Clementino, São Paulo 04039-032, Brazil. leanbio39@yahoo.com.br

Received: November 13, 2022
Peer-review started: November 13, 2022
First decision: December 1, 2022
Revised: December 11, 2022
Accepted: February 8, 2023
Article in press: February 8, 2023
Published online: March 15, 2023

Abstract

Ca²⁺/cAMP ratio could serve as an inflammatory index for diseases like hyp-ertension, diabetes, and coronavirus disease 2019.

Keywords: Ca²⁺/cAMP ratio, COVID-19, Inflammatory index, Diabetes

Core Tip: Ca²⁺/cAMP ratio could serve as an inflammatory index for diseases like hypertension, diabetes, and coronavirus disease 2019.